Mitochondrial Function, Oxidative Stress, Inflammation and Thrombolytic Treatment in Ischemic Stroke
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110289 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eleonora Kovacheva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Oxidative Stress, Mitochondria, Ischemic Stroke, Inflammation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, Medical University of Plovdiv, European Union-NextGenerationEU.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke (IS) is a leading cause of mortality worldwide, responsible for approximately 55% of all neurological disabilities. Proper brain function requires continuous energy supply, primarily generated by mitochondria. Cerebral ischemia impairs the functioning of mitochondrial electron transport chain, reducing adenosine triphosphate production and increasing reactive oxygen species. Inflammation also plays a critical role throughout all stroke phases. YKL-40, a pro-inflammatory glycoprotein, serves as a biomarker of macrophage and microglial activation, while YKL-39 regulates autoimmunity, tissue remodeling, and exhibits monocyte chemotactic and pro-angiogenic activity. This study aims to investigate mitochondrial bioenergetics, oxidative stress, and inflammation in IS patients before and after thrombolysis. Bioenergetic parameters were assessed using Mito Stress Test on an Agilent Seahorse analyzer, and YKL-39, YKL-40 and 4-HNE plasma levels via ELISA. Pre-thrombolytic IS patients demonstrated significantly reduced basal respiration and spare respiratory capacity, along with lower plasma YKL-40 levels. In contrast, they exhibited higher plasma YKL-39 concentrations and increased oxidative stress marker 4-hydroxy-2-nonenal compared to post-thrombolytic patients. These findings highlight novel associations between mitochondrial dysfunction, oxidative stress, and inflammation in IS, and suggest that parameters reflecting these processes may serve as potential biomarkers for evaluating disease severity and predicting outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
- Research Institute, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
- Neurology Ward, University Hospital Pulmed, 4000 Plovdiv, Bulgaria.
ORCID-Profile: Valentina Mihaylova, Victoria Sarafian
Förderung
- European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
- Medical University of Plovdiv
- European Union-NextGenerationEU
Zitieren
APA
Kovacheva, E., Gevezova, M., Koeva, M., Mihaylova, V., Kormova, V., Kostadinova, E., Kostadinova, Y., Kazakova, M., & Sarafian, V. (2025). Mitochondrial Function, Oxidative Stress, Inflammation and Thrombolytic Treatment in Ischemic Stroke. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110289
Vancouver
Kovacheva E, Gevezova M, Koeva M, Mihaylova V, Kormova V, Kostadinova E, et al. Mitochondrial Function, Oxidative Stress, Inflammation and Thrombolytic Treatment in Ischemic Stroke. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110289
BibTeX
@article{Kovacheva2025,
author = {Kovacheva, Eleonora and Gevezova, Maria and Koeva, Margarita and Mihaylova, Valentina and Kormova, Vasilka and Kostadinova, Emanuela and Kostadinova, Yulia and Kazakova, Maria and Sarafian, Victoria},
title = {Mitochondrial Function, Oxidative Stress, Inflammation and Thrombolytic Treatment in Ischemic Stroke},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110289}
}
EUVIMED